Neko Health Raises $700M Series C, Hits 100K Members
16 Jul 2026
Neko Health Raises $700M Series C, Reports 100,000 Members and Clinic-Level Profitability
Neko Health has closed a $700 million Series C funding round, alongside disclosures that the health-tech company now has 100,000 members and has reached profitability at the clinic level. CEO Hjalmar Nilsonne commented on the funding and membership growth, though the exact content of his remarks was not included in available reporting.
![Neko Health's Stockholm clinic, where CEO Hjalmar Nilsonne says the company is now profitable at the clinic level.]
What we know
- Neko Health raised $700 million in a Series C round.
- The company reports 100,000 members.
- Neko Health says it is profitable at the clinic level.
- The company operates a clinic in Stockholm.
- CEO Hjalmar Nilsonne addressed the funding round and membership growth publicly.
What's missing
Several important details were not available in the source material, including Neko Health's post-round valuation, who led or participated in the Series C, the total number of clinics the company operates beyond Stockholm, the precise meaning of "clinic-level profitability" relative to overall company financials, the specific quote from CEO Nilsonne, the company's business model or pricing structure, and the time period over which membership grew to 100,000.
Why founders should care
The size of this raise — $700 million — likely signals strong investor confidence in health-tech models that combine membership subscriptions with in-person clinical services. Founders building in capital-intensive health sectors may find it encouraging that Neko Health is highlighting clinic-level profitability even before (presumably) reaching full company-wide profitability; this suggests investors and markets may be willing to credit unit economics as a proof point, even when broader profitability timelines remain unclear.
The 100,000-member figure may also point to real consumer appetite for preventive health screening services. However, founders should treat this cautiously: without knowing the growth timeframe, it's difficult to gauge whether this reflects rapid traction or a longer accumulation. Similarly, reliance on a single reported clinic location raises questions about how replicable this profitability is across new markets — a pattern founders in physical-location health or wellness businesses should watch closely before assuming their own unit economics will scale the same way.
The caveats
Two risks are worth flagging. First, clinic-level profitability does not necessarily translate into company-level profitability — overhead, R&D, and expansion costs elsewhere in the business could still result in net losses. Second, the reliance on a single reported clinic (Stockholm) may indicate limited geographic diversification at this stage, which matters for founders assessing how quickly a health-tech model can realistically expand.
Bottom line
Neko Health's $700 million raise, paired with reported membership growth and clinic-level profitability, points to investor appetite for hybrid membership-clinical health models. But key financial and operational details — valuation, investor lineup, clinic count, and the definition of profitability being used — remain undisclosed, leaving founders with a promising signal but an incomplete picture.